
The GC Therapeutics co-founder has moved from neural gels to spaceflight to a library for programming cell fate. Her recurring move is simple to describe and difficult to execute: turn biology's long recipes into instructions.

He trained in cell biology, learned to read biotech through markets and corporate strategy, and now leads Syntax Bio as it turns a laboratory insight into a repeatable process.